Traitement de tla sclérose en plaques: nouveautés et complications [New treatment options in multiple sclerosis and their complications].

Details

Serval ID
serval:BIB_8385AEC5E86A
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Title
Traitement de tla sclérose en plaques: nouveautés et complications [New treatment options in multiple sclerosis and their complications].
Journal
Revue Médicale Suisse
Author(s)
Schluep M., Lalive P.H., Du Pasquier R.A.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
2013
Volume
9
Number
384
Pages
940-943
Language
french
Notes
Publication types: English Abstract ; Journal Article Publication Status: ppublish
Abstract
A new therapeutic era opened for multiple sclerosis (MS) with the appearance of molecules given p.o. and/or molecules with greater efficiency. Early diagnosis is critical, as the time and the choice of therapeutic intervention. The initiation of treatments must be personalized, including the risks associated with MS and those potentially related to the treatment chosen, answering the question <Who, when and how to treat?>. Monitoring tools that allow to objectively evaluate: I) MS activity and aggressiveness for each patient and 2) the safety of treatments and their risks of complications, must be further investigated.
Keywords
Drug Therapy/adverse effects, Humans, Multiple Sclerosis/drug therapy
Pubmed
Create date
19/08/2013 17:16
Last modification date
03/03/2018 18:52
Usage data